Cargando…
RNA-based therapies: A cog in the wheel of lung cancer defense
Lung cancer (LC) is a heterogeneous disease consisting mainly of two subtypes, non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), and remains the leading cause of death worldwide. Despite recent advances in therapies, the overall 5-year survival rate of LC remains less than 20%. T...
Autores principales: | Khan, Parvez, Siddiqui, Jawed Akhtar, Lakshmanan, Imayavaramban, Ganti, Apar Kishor, Salgia, Ravi, Jain, Maneesh, Batra, Surinder Kumar, Nasser, Mohd Wasim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977189/ https://www.ncbi.nlm.nih.gov/pubmed/33740988 http://dx.doi.org/10.1186/s12943-021-01338-2 |
Ejemplares similares
-
MicroRNA-1 attenuates the growth and metastasis of small cell lung cancer through CXCR4/FOXM1/RRM2 axis
por: Khan, Parvez, et al.
Publicado: (2023) -
Chimeric antibody targeting unique epitope on onco-mucin16 reduces tumor burden in pancreatic and lung malignancies
por: Shah, Ashu, et al.
Publicado: (2023) -
Mucins as Potential Biomarkers for Early Detection of Cancer
por: Gautam, Shailendra K., et al.
Publicado: (2023) -
Novel HER3/MUC4 oncogenic signaling aggravates the tumorigenic phenotypes of pancreatic cancer cells
por: Lakshmanan, Imayavaramban, et al.
Publicado: (2015) -
GDF15 promotes prostate cancer bone metastasis and colonization through osteoblastic CCL2 and RANKL activation
por: Siddiqui, Jawed Akhtar, et al.
Publicado: (2022)